WeightWatchers clinicians can prescribe compounded semaglutide if they determine that a GLP-1 weight-loss medication is appropriate for a patient. Eligible members can use their insurance for brand-name medications or choose to self-pay for brand-name medications or compounded semaglutide. Only patients meeting clinical eligibility requirements will be prescribed a compounded GLP-1; the clinical eligibility requirements for compounded GLP-1s are the same as for brand-name medications. If prescribed, WeightWatchers members receive their compounded semaglutide within 1-3 business days. The compounding groups Outsourcing Facilities Association and FarmaKeio Custom Compounding filed a complaint regarding the FDA's removal of Eli Lilly And Co's LLY Tirzepatide from the shortage list.